(Q38301654)

1 September 2017

title

Downregulation of MLL-CBP fusion gene expression is associated with differentiation of SN-1 cells with t(11;16)(q23;p13). (English)

1 reference

1 September 2017

N Niitsu

1

1 reference

1 September 2017

Y Hayashi

series ordinal

2

1 reference

1 September 2017

Y Honma

series ordinal

3

1 reference

1 September 2017

language of work or name

English

0 references

publication date

1 January 2001

1 reference

1 September 2017

1 reference

1 September 2017

volume

20

1 reference

1 September 2017

issue

3

1 reference

1 September 2017

page(s)

375-384

1 reference

https://scigraph.springernature.com/pub.10.1038/sj.onc.1204081

1 September 2017

exact match

0 references

cites work

Comparison between the effect of butyric acid and its prodrug pivaloyloxymethylbutyrate on histones hyperacetylation in an HL-60 leukemic cell line

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

The CBP co-activator is a histone acetyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

The translocation t(8;16)(p11;p13) of acute myeloid leukaemia fuses a putative acetyltransferase to the CREB-binding protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

Nuclear receptor coactivator ACTR is a novel histone acetyltransferase and forms a multimeric activation complex with P/CAF and CBP/p300

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

Phosphorylated CREB binds specifically to the nuclear protein CBP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

The mll-AF9 gene fusion in mice controls myeloproliferation and specifies acute myeloid leukaemogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

Detection of CBP rearrangements in acute myelogenous leukemia with t(8;16).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

9-cis retinoic acid is a high affinity ligand for the retinoid X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

Establishment of an inducible expression system of chimeric MLL-LTG9 protein and inhibition of Hox a7, Hox b7 and Hox c9 expression by MLL-LTG9 in 32Dcl3 cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

Retinobenzoic acids. 1. Structure-activity relationships of aromatic amides with retinoidal activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

An anti-cancer derivative of butyric acid (pivalyloxmethyl buterate) and daunorubicin cooperatively prolong survival of mice inoculated with monocytic leukaemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

Distinct roles of the co-activators p300 and CBP in retinoic-acid-induced F9-cell differentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

Nuclear protein CBP is a coactivator for the transcription factor CREB

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

Immortalization and leukemic transformation of a myelomonocytic precursor by retrovirally transduced HRX-ENL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

Characterization of three RXR genes that mediate the action of 9-cis retinoic acid

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

Effect of polar organic compounds on leukemic cells. Butyrate-induced partial remission of acute myelogenous leukemia in a child.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

The transcriptional coactivators p300 and CBP are histone acetyltransferases

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

A human retinoic acid receptor which belongs to the family of nuclear receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

Rubinstein-Taybi syndrome caused by mutations in the transcriptional co-activator CBP

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

Butyric acid: a small fatty acid with diverse biological functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

11q23/MLL rearrangement confers a poor prognosis in infants with acute lymphoblastic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

The critical role of chromosome translocations in human leukemias.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

Molecular genetics of childhood cancer: implications for pathogenesis, diagnosis, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

The p300/CBP family: integrating signals with transcription factors and chromatin

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

The oncogenic capacity of HRX-ENL requires the transcriptional transactivation activity of ENL and the DNA binding motifs of HRX.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

MLL is fused to CBP, a histone acetyltransferase, in therapy-related acute myeloid leukemia with a t(11;16)(q23;p13.3).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

Steroid receptor coactivator-1 is a histone acetyltransferase

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

Rearrangement of the MLL gene in acute lymphoblastic and acute myeloid leukemias with 11q23 chromosomal translocations

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

Transcriptional control. Sinful repression

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

A p300/CBP-associated factor that competes with the adenoviral oncoprotein E1A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

Reversible arrest of proliferation of rat 3Y1 fibroblasts in both the G1 and G2 phases by trichostatin A

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

Enhancement of HL-60 differentiation by a new class of retinoids with selective activity on retinoid X receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

7 January 2021

Apoptosis induced by the histone deacetylase inhibitor sodium butyrate in human leukemic lymphoblasts.

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

7 January 2021

Effect of the retinoid X receptor-selective ligand LGD1069 on mammary carcinoma after tamoxifen failure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

7 January 2021

Single-Step Method of RNA Isolation by Acid Guanidinium Thiocyanate–Phenol–Chloroform Extraction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

7 January 2021

Ten novel 11q23 chromosomal partner sites. European 11q23 Workshop participants

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

7 January 2021

Induction of differentiation of human acute non-lymphocytic leukemia cells in primary culture by inducers of differentiation of human myeloid leukemia cell line HL-60

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

7 January 2021

Dicarba-closo-dodecaboranes as a pharmacophore. Retinoidal antagonists and potential agonists

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

7 January 2021

Clinical pharmacology of sodium butyrate in patients with acute leukemia

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

7 January 2021

Initial clinical trial of a selective retinoid X receptor ligand, LGD1069

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

7 January 2021

Novel anticancer prodrugs of butyric acid. 2

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

7 January 2021

Differentiation Therapy of Acute Promyelocytic Leukemia with Tretinoin (All-trans-Retinoic Acid)

1 reference

https://api.crossref.org/works/10.1038%2FSJ.ONC.1204081

7 January 2021

Identifiers

DOI

10.1038/SJ.ONC.1204081

1 reference

Dimensions Publication ID

1 September 2017

1003173259

0 references

1 reference